The given sequence checksum does not match our current record for P56817!
P56817 (BACE1_HUMAN) Homo sapiens (Human)
Beta-secretase 1 UniProtKBInterProSTRINGInteractive Modelling
501 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6);
2 identical sequences: Pan troglodytes: A0A803KHP3, K7BR34
It is possible new templates exist for this target since these models were created.
Available Structures
431 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE AND EXOSITE BINDING PEPTIDE INHIBITOR |
Heteromer | 4×EDO; | ||||
| Assess | ||||||
| Structure Basis of Allosteric Inhibition of BACE1 by an Exosite-Binding Antibody |
Heteromer | |||||
| Assess | ||||||
| VHS domain of human GGA1 complexed with C-terminal phosphopeptide from BACE |
Heteromer Q9UJY5; | 3×IOD; | ||||
| Assess | ||||||
| VHS domain of human GGA1 complexed with C-terminal peptide from BACE |
Heteromer Q9UJY5; | |||||
| Assess | ||||||
| Complex of GGA1-VHS domain and beta-secretase C-terminal phosphopeptide |
Heteromer Q9UJY5; | |||||
| Assess | ||||||
| Structure of BACE bound to SCH346572 | homo-2-mer | 2×G00; | ||||
| Assess | ||||||
| Structure of BACE bound to SCH12472 | homo-2-mer | 2×D8Y; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase Complexed with inhibitor | homo-2-mer | 2×QIN; | ||||
| Assess | ||||||
| Structure of BACE Bound to (S)-4-(3'-methoxy-[1,1'-biphenyl]-3-yl)-1,4-dimethyl-6-oxotetrahydropyri… | homo-2-mer | 2×H24; 2×TLA; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH743641 | homo-2-mer | 2×TLA; 2×Z75; | ||||
| Assess | ||||||
| Structure of BACE bound to SCH708236 | homo-2-mer | 2×3TO; 2×TLA; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH747123 | homo-2-mer | 2×TLA; 2×Z76; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH745132 | homo-2-mer | 2×TLA; 2×Z74; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 27 | homo-2-mer | 6×IOD; 2×C27; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 24 | homo-2-mer | 6×IOD; 2×H24; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 8c | homo-2-mer | 4×IOD; 2×C8C; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase Complexed with Spiropiperdine Iminohydantoin Inhibitor | homo-2-mer | 2×SII; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with bms-681889 aka n~1~-but… | homo-2-mer | 2×3HH; 2×SO4; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with bms-655295 aka n~3~-((1… | homo-2-mer | 2×3HF; 2×IOD; 2×GOL; | ||||
| Assess | ||||||
| Structure of BACE complexed to compound 3a | homo-2-mer | 2×3MR; | ||||
| Assess | ||||||
| BACE1 compound 28 | monomer | 1×B7E; | ||||
| Assess | ||||||
| Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib… | monomer | 1×NI; 1×2X5; | ||||
| Assess | ||||||
| Synthesis, Characterization and PK/PD Studies of a Series of Spirocyclic Pyranochromene BACE1 Inhib… | monomer | 1×NI; 1×2X4; | ||||
| Assess | ||||||
| Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | monomer | 3×ZN; 1×1B8; | ||||
| Assess | ||||||
| Aminooxazoline inhibitor of BACE-1 | monomer | 1×NI; 1×1WP; | ||||
| Assess | ||||||
| Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | monomer | 3×ZN; 1×1B9; | ||||
| Assess | ||||||
| Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | monomer | 1×NI; 1×1M7; | ||||
| Assess | ||||||
| Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | monomer | 1×NI; 1×1M6; | ||||
| Assess | ||||||
| Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly… | monomer | 3×ZN; 1×0ZA; | ||||
| Assess | ||||||
| Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | monomer | 2×NI; 1×1M4; | ||||
| Assess | ||||||
| Spirocyclic Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors | monomer | 2×NI; 1×1M5; | ||||
| Assess | ||||||
| Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | monomer | 3×ZN; 1×1BF; | ||||
| Assess | ||||||
| Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly… | monomer | 3×ZN; 1×1CH; | ||||
| Assess | ||||||
| SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors | monomer | 4×ZN; 1×842; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH589432 | monomer | 1×CS5; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 14g | monomer | 1×0UP; 2×ZN; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 1 | monomer | 1×091; 6×EDO; 1×ZN; | ||||
| Assess | ||||||
| 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy… | monomer | 1×NI; 1×3UY; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 5 | monomer | 1×092; 2×EDO; 1×PEG; 1×ZN; | ||||
| Assess | ||||||
| Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly… | monomer | 1×1BB; 4×ZN; | ||||
| Assess | ||||||
| 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy… | monomer | 1×NI; 1×3UW; | ||||
| Assess | ||||||
| 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy… | monomer | 1×NI; 1×3UX; | ||||
| Assess | ||||||
| Discovery of 7-THP chromans: BACE1 inhibitors that reduce A-beta in the CNS | monomer | 1×NI; 1×2EX; | ||||
| Assess | ||||||
| 8-Tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzy… | monomer | 1×NI; 1×3J9; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 12a | monomer | 1×0UQ; 1×ZN; 1×EDO; | ||||
| Assess | ||||||
| Design and Synthesis of Thiophene Dihydroisoquinolins as Novel BACE-1 Inhibitors | monomer | 3×ZN; 1×1B7; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 8 | monomer | 1×09A; 1×ZN; 1×EDO; 1×PEG; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 12 | monomer | 1×09D; 2×EDO; 1×PEG; 2×ZN; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 14 | monomer | 1×09F; 2×EDO; 1×PEG; 1×ZN; | ||||
| Assess | ||||||
| Crystal structure of human BACE-1 bound to Compound 24B | monomer | 1×3VO; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 11 | monomer | 1×09G; 4×EDO; 1×PEG; 1×ZN; | ||||
| Assess | ||||||
| Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors | monomer | 3×ZN; 1×1BE; | ||||
| Assess | ||||||
| Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the cataly… | monomer | 3×ZN; 1×1BS; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 9 | monomer | 1×09B; 2×EDO; 1×PEG; 1×ZN; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 6 | monomer | 1×095; 2×EDO; 1×PEG; 2×ZN; | ||||
| Assess | ||||||
| Crystal Structure of BACE with Compound 13 | monomer | 1×09E; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #32 | monomer | 1×QKA; 3×GOL; 1×SO4; | ||||
| Assess | ||||||
| BACE crystal structure with hydroxy pyrrolidine inhibitor | monomer | 1×DJV; 4×GOL; | ||||
| Assess | ||||||
| BACE crystal structure with hydroxy pyrrolidine inhibitor | monomer | 1×DJS; 2×GOL; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #17 | monomer | 1×QJV; 2×GOL; 1×SO4; | ||||
| Assess | ||||||
| BACE crystal structure with hydroxy morpholine inhibitor | monomer | 1×DK7; 2×GOL; | ||||
| Assess | ||||||
| Structure of BACE1 bound to SCH626485 | monomer | 1×CS5; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL-8234 AND EXOSITE PEPTIDE | monomer | 1×BSD; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with a pyrazole-substituted tetrahydropyran thioamidine | monomer | 1×SI5; 2×IOD; 2×GOL; 3×DMS; | ||||
| Assess | ||||||
| Crystal structure of BACE-1 in complex with inhibitor | monomer | 5×CL; 1×012; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-(3-((4S,5S)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1… | monomer | 7×IOD; 2×DMS; 1×C7X; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with (S)-N-(3-(2-amino-6-(fluoromethyl)-4 -methyl-4H-1,3-oxaz… | monomer | 5×IOD; 3×GOL; 1×0B6; | ||||
| Assess | ||||||
| APO Structure of BACE1 | monomer | 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of BACE-1 in complex with inhibitor | monomer | 1×009; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #6 | monomer | 1×ZQS; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #34 | monomer | 1×QK7; 2×GOL; | ||||
| Assess | ||||||
| BACE1 in complex with (R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-… | monomer | 1×66F; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #3 | monomer | 1×QJJ; 1×QJM; 2×GOL; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 1×VTI; 2×SO4; | ||||
| Assess | ||||||
| APO structure of BACE1 | monomer | 8×SO4; 1×CL; 4×URE; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 1×ZPZ; 3×SO4; 7×URE; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of human beta secretase complexed with inhibitor | monomer | 1×5HA; | ||||
| Assess | ||||||
| BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(isonicotinamido)cyclohexyl)methyl)-… | monomer | 1×3KU; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #18 | monomer | 1×ZRD; 1×GOL; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | monomer | 1×6Z0; 2×NA; 1×DMS; | ||||
| Assess | ||||||
| Design and synthesis of thiophene dihydroisoquinolins as novel BACE-1 inhibitors | monomer | 1×1BC; 3×ZN; 2×NA; | ||||
| Assess | ||||||
| Crystal structure of human Beta-secretase complexed with inhibitor | monomer | 1×I02; | ||||
| Assess | ||||||
| Crystal structure of Human Bace-1 bound to inhibitor | monomer | 1×L00; | ||||
| Assess | ||||||
| Crystal structure of human beta secretase complexed with inhibitor | monomer | 1×MY9; | ||||
| Assess | ||||||
| Crystal structure of human Beta-secretase complexed with L-L000430,469 | monomer | 1×3BN; | ||||
| Assess | ||||||
| Structure of Beta-Secretase Complexed with Inhibitor | monomer | |||||
| Assess | ||||||
| BACE1 in complex with (S)-5-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-2,5-dimethyl… | monomer | 1×66J; | ||||
| Assess | ||||||
| New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain | monomer | 1×DMS; 1×1B1; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-(3-((4S,5R)-2-amino-4-methyl-5-phenyl-5,6-dihydro-4H-1… | monomer | 6×IOD; 1×DMS; 1×C6R; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with hydroxyethylamine inhibitor 37 | monomer | 1×0K9; 2×GOL; | ||||
| Assess | ||||||
| Structure of BACE-1 in complex with Ligand 13 | monomer | 1×M7D; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 4×SO4; | ||||
| Assess | ||||||
| Crystal Structure of Beta-secretase complexed with Inhibitor OM00-3 | monomer | |||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H… | monomer | 3×IOD; 2×GOL; 1×66F; | ||||
| Assess | ||||||
| BACE-1 in complex with ligand 12 | monomer | 5×IOD; 1×GOL; 3×DMS; 1×0EW; | ||||
| Assess | ||||||
| Crystal structure of human Beta-secretase complexed with inhibitor | monomer | 1×I03; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 1×ZPY; 2×SO4; | ||||
| Assess | ||||||
| BACE-1 complexed with compound 1 | monomer | 1×AEF; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 13 | monomer | 1×1R8; 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| BACE-1 complexed with compound 4 | monomer | 1×AED; | ||||
| Assess | ||||||
| BACE-1 complexed with compound 2 | monomer | 1×AEG; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-5,6-dihydro-4H-1,3-thiazin-4… | monomer | 3×IOD; 1×NA; 2×GOL; 1×C6U; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-… | monomer | 6×IOD; 1×GOL; 1×C7O; | ||||
| Assess | ||||||
| BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylthio)pyrimidin… | monomer | 1×954; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH734723 | monomer | 1×TAR; 1×SC7; | ||||
| Assess | ||||||
| Structure of BACE Bound to 5-(3-(5-chloropyridin-3-yl)phenyl)-5-cyclopropyl-2-imino-3-methylimidazo… | monomer | 1×0KQ; 1×TLA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (1SR,2SR)-2-((R)-2-amino-5,5-difluoro-4-methyl-5,6-dihy… | monomer | 2×NA; 2×DMS; 1×5T7; 1×GOL; 1×ACT; | ||||
| Assess | ||||||
| BACE-1 in complex with (4aR,7aS)-7a-(2,6-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-… | monomer | 1×60T; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH736062 | monomer | 1×TAR; 1×BDW; | ||||
| Assess | ||||||
| Crystal Structure of Human BACE-1 in Complex with amino-1,4-oxazine compound 4 | monomer | 1×D9W; | ||||
| Assess | ||||||
| BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methyl-6-(methylamino)pyrimidi… | monomer | 1×TLA; 1×60S; | ||||
| Assess | ||||||
| BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((1S,3R)-3-(cyclopentylamino)cyclohexyl)methyl)… | monomer | 1×TLA; 1×3KT; | ||||
| Assess | ||||||
| BACE-1 incomplex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoro-4-methoxypyrimidin-2-yl… | monomer | 1×TLA; 1×60W; | ||||
| Assess | ||||||
| Crystal structure of bace1 with novel inhibitor | monomer | 3×SO4; 1×URE; 1×PEG; | ||||
| Assess | ||||||
| Structure of BACE Bound to 2-fluoro-5-(5-(2-imino-3-methyl-4-oxo-6-phenyloctahydro-1H-pyrrolo[3,4-d… | monomer | 1×TLA; 1×10W; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(cyclohexylamino)-2-hydroxy- 1-(phenylmethyl)propyl)-3-(e… | monomer | 1×VG7; | ||||
| Assess | ||||||
| Crystal structure of BACE1 complexed with an inhibitor | monomer | 1×5HA; 8×CL; 11×URE; 2×SO4; | ||||
| Assess | ||||||
| BACE-1 in complex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(4-ethoxy-5-fluoro-6-methylpyrimidin-2-yl)… | monomer | 1×60U; | ||||
| Assess | ||||||
| BACE-1 in complex with (7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-6-(5-fluoropyrimidin-2-yl)-3-methy… | monomer | 1×TLA; 1×60Y; | ||||
| Assess | ||||||
| BACE crystal structure with tricyclic aminothiazine inhibitor | monomer | 1×4RY; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH722924 | monomer | 2×TAR; 1×CS7; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 1×ZPX; 3×SO4; 2×URE; 1×CL; | ||||
| Assess | ||||||
| Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(6-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H… | monomer | 1×TLA; 1×10O; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH736201 | monomer | 1×TAR; 1×BDX; | ||||
| Assess | ||||||
| BACE-1 in complex with (4aR,7aS)-7a-(2,4-difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-… | monomer | 1×60X; | ||||
| Assess | ||||||
| BACE-1 incomplex with (7aR)-7a-(5-cyanothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)… | monomer | 1×60V; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH727596 | monomer | 1×314; 1×TAR; | ||||
| Assess | ||||||
| Structure of BACE Bound to 2-imino-5-(3'-methoxy-[1,1'-biphenyl]-3-yl)-3-methyl-5-phenylimidazolidi… | monomer | 1×0KM; 1×TLA; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH735310 | monomer | 1×TAR; 1×CS9; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH709583 | monomer | 1×316; 1×TAR; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH723873 | monomer | 1×TAR; 1×BDV; | ||||
| Assess | ||||||
| Crystal Structure of BACE with amino thiazine inhibitor LY2886721 | monomer | 1×3YS; 1×GOL; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5S)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1H6; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1HM; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH713601 | monomer | 1×TAR; 1×BDO; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH726222 | monomer | 1×318; 1×TAR; | ||||
| Assess | ||||||
| Structure of BACE bound to SCH743813 | monomer | 1×74A; 1×TLA; | ||||
| Assess | ||||||
| Crystal Structure of human Beta Secretase complexed with IXS | monomer | 1×IXS; | ||||
| Assess | ||||||
| Structure of BACE Bound to 2-imino-3-methyl-5,5-diphenylimidazolidin-4-one | monomer | 1×0KK; 1×TLA; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH723871 | monomer | 1×TAR; 1×BDQ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-di… | monomer | 2×NA; 1×DMS; 1×1HQ; | ||||
| Assess | ||||||
| BACE1 in complex with 4-(3-(furan-2-carboxamido)phenyl)-1-methyl-5-oxo-4-phenylimidazolidin-2-imini… | monomer | 1×TLA; 1×66H; | ||||
| Assess | ||||||
| Structure of BACE Bound to (S)-3-(5-(2-imino-1,4-dimethyl-6-oxohexahydropyrimidin-4-yl)thiophen-3-y… | monomer | 1×TLA; 1×13W; | ||||
| Assess | ||||||
| Structure of BACE Bound to 2-((7aR)-7a-(4-(3-cyanophenyl)thiophen-2-yl)-2-imino-3-methyl-4-oxohexah… | monomer | 1×TLA; 1×10Q; | ||||
| Assess | ||||||
| Structure of BACE Bound to (R)-5-cyclopropyl-2-imino-3-methyl-5-(3-(5-(prop-1-yn-1-yl)pyridin-3-yl)… | monomer | 1×0KR; 1×TLA; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH745966 | monomer | 1×SC6; 1×TAR; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH {(1R,2R)-2-[(R)-2-Amino-4-(4-difluoromethoxy-phenyl)-4,… | monomer | 1×5T5; 2×NA; 1×DMS; | ||||
| Assess | ||||||
| BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-4-(((R)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)met… | monomer | 1×3KO; | ||||
| Assess | ||||||
| A multiconformer ligand model of 5T5 bound to BACE-1 | monomer | 2×NA; 1×DMS; 1×5T5; | ||||
| Assess | ||||||
| Structure of BACE Bound to 2-imino-3-methyl-5-phenyl-5-(3-(pyridin-3-yl)phenyl)imidazolidin-4-one | monomer | 1×0KP; 1×TLA; | ||||
| Assess | ||||||
| BACE crystal structure with bicyclic aminothiazine inhibitor | monomer | 1×4RZ; 1×GOL; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #22 | monomer | 1×ZR7; | ||||
| Assess | ||||||
| Structure of Bace-1 in complex with Ligand 8 | monomer | 1×HRV; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1H7; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-[3-[(3-chloro-8-quinolyl)amino]phenyl]-5-methyl-2,6-d… | monomer | 2×NA; 1×DMS; 1×5T8; | ||||
| Assess | ||||||
| Structure of BACE Bound to 3-(5-((7aR)-2-imino-6-(3-methoxypyridin-2-yl)-3-methyl-4-oxooctahydro-1H… | monomer | 1×TLA; 1×10V; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-4-me… | monomer | 2×NA; 1×DMS; 1×1H8; | ||||
| Assess | ||||||
| BACE-1 in complex with 2-(((1R,3S)-3-(((R)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidi… | monomer | 2×TLA; 1×3KW; | ||||
| Assess | ||||||
| Structure of BACE Bound to SCH710413 | monomer | 1×TAR; 1×BDJ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((S)-2-amino-5,5-… | monomer | 2×NA; 1×DMS; 1×1HO; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Ethoxy-pyridine-2-carboxylic acid [3-((R)-2-amino-5,5… | monomer | 2×NA; 1×DMS; 1×6T9; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihyd… | monomer | 4×IOD; 1×0QQ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6R)-2-ami… | monomer | 2×NA; 1×DMS; 1×1HH; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | monomer | 1×WZV; 2×NA; 1×DMS; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH (4S)-4-[3-(5-chloro-3-pyridyl)phenyl]-4-[4-(difluoromet… | monomer | 1×5T6; 1×DMS; 2×NA; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,5R)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1H5; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4R,5R,6S)-2-ami… | monomer | 2×NA; 1×DMS; 1×1HG; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6R)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1HJ; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH 5-Cyano-pyridine-2-carboxylic acid [3-((4S,6S)-2-amino-… | monomer | 2×NA; 1×DMS; 1×1HL; | ||||
| Assess | ||||||
| Structure of bace (beta secretase) in Complex with EV0 | monomer | 1×EV0; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | monomer | 1×8T3; 2×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl]-4- fluo… | monomer | 4×IOD; 1×GOL; 1×H3C; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(2,6-dimethoxy-benzyl)-p… | monomer | 1×F1I; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(3S)-1-amino-5-fluoro-3-methyl-3,4-dihydro-2,6-nap… | monomer | 4×IOD; 3×GOL; 1×GUC; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH CHEMICAL LIGAND | monomer | 1×XK0; 2×NA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihyd… | monomer | 2×IOD; 1×GOL; 1×DMS; 1×C83; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with OM99-2 at pH 5.0 | monomer | |||||
| Assess | ||||||
| human Bace (beta secretase) in complex with Cyclohexanecarboxylic acid (2-(2-am ino-6-phenoxy-4H-qu… | monomer | 1×QUD; | ||||
| Assess | ||||||
| BACE-1 IN COMPLEX WITH LIGAND 32397778 | monomer | 1×III; 1×CL; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH Pep#3 | monomer | 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin… | monomer | 1×F1K; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-AVI326 | monomer | 1×0GO; | ||||
| Assess | ||||||
| Structure of BACE in complex with (S)-4-(3-chloro-5-(5-(prop-1-yn-1-yl)pyridin-3-yl)thiophen-2-yl)-… | monomer | 1×0V6; | ||||
| Assess | ||||||
| BACE1 in complex with 4-(cyclohexylamino)-1-(3-fluorophenyl)-8-(3-isopropoxybenzyl)-1,3,8-triazaspi… | monomer | 1×4QA; | ||||
| Assess | ||||||
| Crystal Structure of Hydroxyethyl Secondary Amine-based Peptidomimetic Inhibitor of Human Beta-Secr… | monomer | 1×F2I; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase Complexed with inhibitor | monomer | 2×SO4; 1×35A; | ||||
| Assess | ||||||
| BACE-1 in complex with (R)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1S,3R)-3-(3-phenylureido)cyclo… | monomer | 2×TLA; 1×779; | ||||
| Assess | ||||||
| BACE-1 in complex with compound #18 | monomer | 1×QJP; 3×GOL; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of bace1 with its inhibitor | monomer | 3×SO4; 1×0U4; 2×URE; | ||||
| Assess | ||||||
| Crystal structure of Bace1 with its inhibitor | monomer | 2×SO4; | ||||
| Assess | ||||||
| Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona… | monomer | 1×P6U; 3×IOD; 2×EDO; | ||||
| Assess | ||||||
| Bace1 with the aminohydantoin Compound R-58 | monomer | 1×569; | ||||
| Assess | ||||||
| Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatme… | monomer | 5×ACT; 1×NA; 1×32D; | ||||
| Assess | ||||||
| BACE1 in complex with 8-(3-((1-aminopropan-2-yl)oxy)benzyl)-4-(cyclohexylamino)-1-(3-fluorophenyl)-… | monomer | 1×4QD; | ||||
| Assess | ||||||
| Crystal structure of human Beta secretase complexed with inhibitor | monomer | 1×32P; | ||||
| Assess | ||||||
| Structure of bace (beta secretase) in complex with inhibitor | monomer | 1×EV3; 7×GOL; | ||||
| Assess | ||||||
| BACE-1 in complex with HEA-type macrocyclic inhibitor, MV078571 | monomer | 1×0XA; 1×ACT; 1×GOL; | ||||
| Assess | ||||||
| Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio… | monomer | 1×1LI; | ||||
| Assess | ||||||
| Crystal structure of BACE with amino thiazine inhibitor LY2811376 | monomer | 1×4B2; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminoquinoline inhibitor 6 | monomer | 1×68J; 1×GOL; | ||||
| Assess | ||||||
| Bace1 with the aminohydantoin Compound 37 | monomer | 1×X45; | ||||
| Assess | ||||||
| Crystal structure of beta-secretase bound to a potent and highly selective inhibitor. | monomer | 1×ZPQ; | ||||
| Assess | ||||||
| Discovery of Pyrrolidine-based b-Secretase Inhibitors: Lead Advancement through Conformational Desi… | monomer | 1×508; 4×SO4; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3… | monomer | 1×F1M; | ||||
| Assess | ||||||
| New substrate binding pockets for beta-secretase. | monomer | |||||
| Assess | ||||||
| Structure of BACE-1 Bound to (7aR)-6-benzoyl-7a-(4-(3-cyanophenyl)thiophen-2-yl)-3-methyl-4-oxohexa… | monomer | 1×10J; | ||||
| Assess | ||||||
| Crystal Structure of Human BACE-1 in Complex with Compound NB-360 (compound 54) | monomer | 1×SLK; | ||||
| Assess | ||||||
| BACE crystal structure with bicyclic aminothiazine fragment | monomer | 1×4RW; 1×GOL; | ||||
| Assess | ||||||
| BACE crystal structure with hydroxy pyrrolidine inhibitor | monomer | 1×DKJ; 2×GOL; | ||||
| Assess | ||||||
| BACE1 in complex with 8-benzyl-4-(cyclohexylamino)-1-(3-fluorophenyl)-7-methyl-1,3,8-triazaspiro[4.… | monomer | 1×4QF; | ||||
| Assess | ||||||
| Crystal Structure of Unbound Beta-Secretase Catalytic Domain. | monomer | |||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase Complexed with inhibitor | monomer | 1×SO4; 1×712; | ||||
| Assess | ||||||
| Crystal structure of Beta-secretase bound to a long inhibitor with additional upstream residues. | monomer | |||||
| Assess | ||||||
| Crystal structure of GRL-8234 bound to BACE (Beta-secretase) | monomer | 1×BSD; | ||||
| Assess | ||||||
| Crystal Structure of beta secetase in complex with 2-amino-3-methyl-6-((1S, 2R)-2-phenylcyclopropyl… | monomer | 5×IOD; 4×GOL; 1×B00; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-bromo-2,3-dimethoxy-b… | monomer | 1×F1L; | ||||
| Assess | ||||||
| Crystal structure of human BACE-1 bound to Compound 36 | monomer | 1×3VP; 5×IOD; 4×DMS; | ||||
| Assess | ||||||
| Crystal structure of BACE1 bound to inhibitor | monomer | 3×SO4; 1×GOL; 1×5MS; | ||||
| Assess | ||||||
| Crystal Structure of beta secetase in complex with 2-amino-6-((1S,2R)-2-(3'-methoxybiphenyl-3-yl)cy… | monomer | 6×IOD; 2×GOL; 1×0B1; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa… | monomer | 2×IOD; 1×GOL; 1×GX6; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with 4-(4-fluoro-benzyl)-piperazin… | monomer | 1×F1J; | ||||
| Assess | ||||||
| Structure of BACE1 in complex with N-(3-((4R,5R,6S)-2-amino-6-(1,1-difluoroethyl)-5-fluoro-4-methyl… | monomer | 2×IOD; 5×GOL; 1×DMS; 1×0B5; | ||||
| Assess | ||||||
| Design and Synthesis of Potent BACE-1 Inhibitors with Cellular Activity: Structure-Activity Relatio… | monomer | 2×SO4; 1×GOL; 1×2LI; | ||||
| Assess | ||||||
| Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor (2) | monomer | 1×LIQ; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4S,6S)-2-amino-4-methyl-6-(trifluoromethyl)-5,6-d… | monomer | 3×IOD; 2×GOL; 1×C86; | ||||
| Assess | ||||||
| Bace1 with the aminohydantoin Compound 29 | monomer | 1×593; | ||||
| Assess | ||||||
| Crystal structure of human beta secretase complexed with NVP-AMK640 | monomer | |||||
| Assess | ||||||
| BACE crystal structure with tricyclic aminothiazine inhibitor | monomer | 1×4RX; | ||||
| Assess | ||||||
| Design and synthesis of hydroxyethylamine (hea) BACE-1 inhibitors: prime side chromane-containing i… | monomer | 1×C6A; | ||||
| Assess | ||||||
| Crystal Structure of BACE1 in complex with N-{3-[(4R)-2-amino-4-(prop-1-yn-1-yl)-5,6-dihydro-4H-1,3… | monomer | 2×IOD; 2×GOL; 1×GTU; | ||||
| Assess | ||||||
| Structure of Bace (beta secretase) in complex with ligand EV2 | monomer | 1×EV2; | ||||
| Assess | ||||||
| Crystal structure of beta-secretase bond to an inhibitor with Isophthalamide Derivatives at P2-P3 | monomer | 1×23I; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N-(3-((4AS,7AS)-2-AMINO-4,4A,5,… | monomer | 1×7H3; | ||||
| Assess | ||||||
| Crystal structure of human BACE-1 bound to Compound 6 | monomer | 1×3WP; 2×IOD; 2×NA; 3×GOL; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with N-(1-benzyl-piperidin-4-yl)-4… | monomer | 1×F1H; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | 1×VSI; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BVI151 | monomer | 1×0GU; 1×IOD; | ||||
| Assess | ||||||
| Crystal structure of the human BACE1 catalytic domain in complex with N-[1-(5-chloro-2-isopropoxy-3… | monomer | 1×F1N; | ||||
| Assess | ||||||
| BACE-1 in complex with ELN380842 | monomer | 1×842; | ||||
| Assess | ||||||
| Crystal Structure of a cycloamide-urethane-derived novel inhibitor bound to human brain memapsin 2 … | monomer | 1×MMI; | ||||
| Assess | ||||||
| X-ray structure of BACE1 in complex with a bicyclic isoxazoline carboxamide as the P3 ligand | monomer | 1×GHJ; 3×GOL; 3×URE; | ||||
| Assess | ||||||
| Structure of BACE1 complex with a syn-HEA-type inhibitor | monomer | |||||
| Assess | ||||||
| Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functiona… | monomer | 1×74B; 3×IOD; 2×NA; 3×GOL; 1×DMS; 2×CL; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | |||||
| Assess | ||||||
| Crystal Structure of Human BACE-1 in Complex with CNP520 | monomer | 1×BUH; | ||||
| Assess | ||||||
| Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse… | monomer | 1×1W0; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BQQ711 | monomer | 1×0GS; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain | monomer | 1×2FB; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminoquinoline compound 1 | monomer | 3×IOD; 1×68M; 1×GOL; | ||||
| Assess | ||||||
| BACE1 IN COMPLEX WITH compound 3 (NB-641) | monomer | 1×SKW; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a soaking experi… | monomer | 1×BXD; | ||||
| Assess | ||||||
| Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse… | monomer | 1×1W2; 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BXQ490 | monomer | 1×BXQ; | ||||
| Assess | ||||||
| Apo Structure of BACE (Beta Secretase) | monomer | 4×IOD; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP… | monomer | 3×ACT; 1×QN7; | ||||
| Assess | ||||||
| Crystal Structure of Human BACE-1 in Complex with Compound 38a (NB-854) | monomer | 1×SL8; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a soaking experi… | monomer | 1×0GT; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49 | monomer | 3×IOD; 1×3LO; 1×GOL; | ||||
| Assess | ||||||
| Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM… | monomer | 3×ACT; 1×NA; 1×7F3; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain | monomer | 1×DMS; 1×54M; | ||||
| Assess | ||||||
| Crystal structure of human Beta Secretase complexed with I21 | monomer | 1×I21; | ||||
| Assess | ||||||
| Crystal structure of BACE1 with its inhibitor | monomer | |||||
| Assess | ||||||
| Design and Synthesis of BACE1 Inhibitors with In Vivo Brain Reduction of beta-Amyloid Peptides (COM… | monomer | 4×ACT; 1×I6X; | ||||
| Assess | ||||||
| co-crystal structure of BACE with inhibitor AM-6494 | monomer | 3×IOD; 2×GOL; 1×P6J; | ||||
| Assess | ||||||
| Diethylaminosulfur Trifluoride-Mediated Intramolecular Cyclization of 2-hydroxy-benzylureas to Fuse… | monomer | 1×1W1; 1×ACT; 1×DMS; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with (Z)-fluoro-olefin containing compound 15 | monomer | 1×U64; 3×IOD; | ||||
| Assess | ||||||
| New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain | monomer | 2×ACT; 1×6TG; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with Compound 11a | monomer | 1×1YS; | ||||
| Assess | ||||||
| New Aminoimidazoles as BACE-1 Inhibitors: From Rational Design to Ab- lowering in Brain | monomer | 1×6T6; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in complex with : N-(3-((1R,5S,6R)-3-amino-5-methyl-2-oxa-4-az… | monomer | 3×IOD; 2×GOL; 1×SO4; 1×EJ7; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC022 | monomer | 1×E51; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC025 | monomer | 1×AFJ; | ||||
| Assess | ||||||
| Crystal structure of human beta-secretase in complex with NVP-AFJ144 | monomer | 1×AFJ; | ||||
| Assess | ||||||
| Bace1 with the aminohydantoin Compound S-34 | monomer | 1×X17; | ||||
| Assess | ||||||
| Human bace-1 complex with bjc060 | monomer | 1×BJC; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC020 hydrolyzed | monomer | 1×GOL; 1×E7A; | ||||
| Assess | ||||||
| Fragment Based Discovery and Optimisation of BACE-1 Inhibitors | monomer | 1×IOD; 1×GOL; 1×EV4; | ||||
| Assess | ||||||
| Crystal structure of human beta secretase complexed with NVP-AUR200 | monomer | |||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with compound 11d | monomer | 1×1YT; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC001 | monomer | 1×E4Y; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BXD552, derived from a co-crystalliza… | monomer | 1×BXD; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC013 | monomer | 1×E74; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC019 hydrolyzed | monomer | 1×GOL; 1×E77; | ||||
| Assess | ||||||
| Crystal structure of human beta-secretase in complex with NVP-BAV544 | monomer | 1×BAV; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC021 | monomer | 1×AR9; | ||||
| Assess | ||||||
| Potent Beta-Secretase 1 hydroxyethylene Inhibitor | monomer | 1×MV7; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC002 | monomer | 1×BAV; | ||||
| Assess | ||||||
| Bace1 in complex with the aminohydantoin Compound 4g | monomer | 1×Z81; | ||||
| Assess | ||||||
| Crystal structure of human beta-secretase in complex with NVP-ARV999 | monomer | 1×AR9; | ||||
| Assess | ||||||
| Crystal Structure of the Bace complex with AXQ093, a macrocyclic inhibitor | monomer | 1×AXQ; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC023 | monomer | 1×AXQ; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC014 | monomer | 1×0BI; | ||||
| Assess | ||||||
| Human BACE-1 complex with NB-216 | monomer | 1×0BI; | ||||
| Assess | ||||||
| BACE1 in complex with a macrocyclic inhibitor | monomer | 1×L3M; 1×SO4; | ||||
| Assess | ||||||
| BACE1 in complex with a macrocyclic inhibitor | monomer | 1×L3J; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene inhibitor 2 | monomer | 3×IOD; 1×GOL; 1×SO4; 1×68L; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC008 | monomer | 1×E5P; | ||||
| Assess | ||||||
| Rational Design and Synthesis of Aminopiperazinones as Beta Secretase (BACE) Inhibitors | monomer | 1×18P; 3×SO4; | ||||
| Assess | ||||||
| SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors. | monomer | 1×1BL; | ||||
| Assess | ||||||
| BACE-1 in complex with ELN475957 | monomer | 1×957; | ||||
| Assess | ||||||
| Crystal structure of beta-secretase 1 in complex with selective beta-secretase 1 inhibitor | monomer | 1×586; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC007 | monomer | 1×E5D; | ||||
| Assess | ||||||
| SPR and structural analysis yield insight towards mechanism of inhibition of BACE inhibitors | monomer | 1×957; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC026 | monomer | 1×E4J; 1×SO4; | ||||
| Assess | ||||||
| Bace-1 with Compound 3 | monomer | 1×454; | ||||
| Assess | ||||||
| Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors | monomer | 1×QBH; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC023 | monomer | 1×E5A; | ||||
| Assess | ||||||
| Human BACE-1 COMPLEX WITH AYH011 | monomer | 1×AYH; | ||||
| Assess | ||||||
| Bace-1 inhibitor complex | monomer | 1×1QU; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC009 | monomer | 1×E6P; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC015 | monomer | 1×E5V; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with compound 12a | monomer | 1×1YU; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with biarylspiro aminooxazoline 6 | monomer | 3×IOD; 1×DWA; 1×DMS; | ||||
| Assess | ||||||
| Crystal Structure of the Bace complex with BDF488, a macrocyclic inhibitor | monomer | 1×AXF; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC024 | monomer | 1×AXF; | ||||
| Assess | ||||||
| Hydroxyethylamine-based inhibitors of BACE1: P1-P3 macrocyclization can improve potency, selectivit… | monomer | 1×1QT; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC011 | monomer | 1×E61; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with NVP-BUR436, derived from a co-crystalliza… | monomer | 1×0GT; | ||||
| Assess | ||||||
| Crystal Structure of Human Beta Secretase in Complex with BFG356 | monomer | 1×3P5; | ||||
| Assess | ||||||
| Structure of BACE complexed to compound 1 | monomer | 1×XX4; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC018 | monomer | 1×E4G; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC003 | monomer | 1×E6V; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC010 | monomer | 1×E6M; | ||||
| Assess | ||||||
| Co-crystal of BACE1 with compound 0211 | monomer | 1×5E7; | ||||
| Assess | ||||||
| Crystal structure of beta-secretase complexed with an amino-ethylene inhibitor | monomer | 1×FRP; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC017 | monomer | 1×E6J; | ||||
| Assess | ||||||
| BACE-1 complexed with compound 3 | monomer | 1×AEH; | ||||
| Assess | ||||||
| Crystal Structure of human beta-secretase (BACE) in the presence of an inhibitor | monomer | 2×PO4; 1×LIJ; | ||||
| Assess | ||||||
| Potent beta-secretase 1 inhibitor | monomer | 1×929; | ||||
| Assess | ||||||
| Potent and selective isophthalamide S2 hydroxyethylamine inhibitor of BACE1 | monomer | 2×PO4; 1×MR0; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC004 | monomer | 1×E6S; | ||||
| Assess | ||||||
| Crystal structure of BACE1 complexed with an inhibitor | monomer | 1×5HA; 1×CL; | ||||
| Assess | ||||||
| BACE (Beta Secretase) in complex with a nanomolar non-peptidic inhibitor | monomer | 4×IOD; 1×L01; | ||||
| Assess | ||||||
| Beta-secretase 1 complexed with statine-based inhibitor | monomer | 1×757; 1×IPA; | ||||
| Assess | ||||||
| Fragment based discovery and optimisation of bace-1 inhibitors | monomer | 1×EV6; 2×IOD; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC005 | monomer | 1×E6Y; | ||||
| Assess | ||||||
| Discovery of aminoheterocycles as a novel beta-secretase inhibitor class | monomer | 1×B35; | ||||
| Assess | ||||||
| Crystal structure of BACE complex with BMC016 | monomer | 1×E4A; | ||||
| Assess | ||||||
| Crystal Structure of BACE-1 in complex with AHM178 | monomer | 1×XLI; | ||||
| Assess | ||||||
| Structure of BACE1 complex with 2-thiophenyl HEA-type inhibitor | monomer | |||||
| Assess | ||||||
| BACE-1 in complex with a HEA-macrocyclic type inhibitor | monomer | 1×0LG; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28 | monomer | 4×IOD; 1×43K; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22 | monomer | 4×IOD; 2×GOL; 1×3UT; | ||||
| Assess | ||||||
| Crystal structure of BACE1 at pH 7.0 | monomer | |||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 2-aminooxazoline-3-azaxanthene compound 12 | monomer | 5×IOD; 1×8QV; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitor | monomer | 1×3LL; 3×IOD; 2×GOL; | ||||
| Assess | ||||||
| BACE-1 in complex with HEA-macrocyclic inhibitor, MV078512 | monomer | 1×0N1; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with hydroxyethylamine-macrocyclic inhibitor 19 | monomer | 3×IOD; 1×1R6; 1×GOL; | ||||
| Assess | ||||||
| BACE1 compound 23 | monomer | 1×B7T; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminooxazoline xanthene 9l | monomer | 2×IOD; 1×DWB; 1×GOL; 1×DMS; | ||||
| Assess | ||||||
| Compound 10 | monomer | 1×GOL; 1×IOD; 1×5QU; | ||||
| Assess | ||||||
| (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-4-methyl-6-pyrimidin-5-yl-5,6-dihydro-1,3-thiazin-2-amin… | monomer | 1×6WD; | ||||
| Assess | ||||||
| Structure of beta-secretase complexed with inhibitor | monomer | 1×0GH; 1×LPD; | ||||
| Assess | ||||||
| X-ray structure of Bace-1 in complex with compound 3.b.10 | monomer | 1×310; | ||||
| Assess | ||||||
| Bace1 with Compound 30 | monomer | 1×472; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 4 | monomer | 2×IOD; 1×DMS; 1×7IP; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminooxazoline xanthene 11a | monomer | 4×IOD; 1×DWD; 2×GOL; | ||||
| Assess | ||||||
| Compound 18 | monomer | 1×GOL; 1×IOD; 1×5QV; | ||||
| Assess | ||||||
| (4~{S},6~{S})-4-[2,4-bis(fluoranyl)phenyl]-6-(3,5-dimethyl-1,2-oxazol-4-yl)-4-methyl-5,6-dihydro-1,… | monomer | 1×IOD; 1×6WE; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with 4-(4-fluorobenzyl)piperidine | monomer | 3×IOD; 1×DMS; 1×4FP; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminoquinoline inhibitor 9 | monomer | 1×68K; | ||||
| Assess | ||||||
| BACE1 in complex with inhibitor 5g | monomer | 3×SO4; 1×8W4; 1×URE; | ||||
| Assess | ||||||
| Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors | monomer | 1×591; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with 1-amino-isoquinoline | monomer | 3×IOD; 1×DMS; 1×1SQ; | ||||
| Assess | ||||||
| Pyrazolyl and Thienyl Aminohydantoins as Potent BACE1 Inhibitors | monomer | 1×532; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 6a | monomer | 2×IOD; 1×DMS; 1×8IP; 1×GOL; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 3 | monomer | 2×IOD; 1×DMS; 1×6IP; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 5 | monomer | 3×IOD; 1×DMS; 1×CMZ; | ||||
| Assess | ||||||
| Crystal Structure of beta secetase in complex with 2-amino-3,6-dimethyl-6-(2-phenylethyl)-3,4,5,6-t… | monomer | 4×GOL; 2×IOD; 1×0B3; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with 3-(2-amino-6-(o-tolyl)quinolin-3-yl)-N-(3,3-dimethylbuty… | monomer | 4×IOD; 2×GOL; 1×6BS; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 7 | monomer | 3×IOD; 1×DMS; 1×IP6; | ||||
| Assess | ||||||
| Bace1 with Compound 38 | monomer | 1×BX2; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-(cyclohexylmethyl)p… | monomer | 4×IOD; 5×GOL; 1×3RU; | ||||
| Assess | ||||||
| Crystal structure of BACE1 at pH 4.5 | monomer | |||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 8b | monomer | 3×IOD; 1×DMS; 1×IP7; | ||||
| Assess | ||||||
| BACE1 in complex with a macrocyclic inhibitor | monomer | 1×L4J; 2×SO4; | ||||
| Assess | ||||||
| Bace-1 with the aminopyridine Compound 32 | monomer | 1×625; | ||||
| Assess | ||||||
| Fragment Based Discovery and Optimisation of BACE-1 Inhibitors | monomer | 2×IOD; 1×EV5; | ||||
| Assess | ||||||
| Crystal structure of BACE1 in complex with aminooxazoline xanthene inhibitor 2 | monomer | 1×3LN; 3×IOD; | ||||
| Assess | ||||||
| Crystal structure of BACE1 at pH 5.0 | monomer | |||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with compound 6b | monomer | 2×IOD; 1×DMS; 1×9IP; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 6-(Thiophen-3-yl)quinolin-2-amine | monomer | 4×IOD; 1×RSV; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in complex with N-((2S,3R)-1-(4-fluorophenyl)-3-hydroxy-4-((6'… | monomer | 7×IOD; 2×GOL; 1×0MP; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in complex with (R)-3-(2-amino-6-o-tolylquinolin-3-yl)-N-((R)-… | monomer | 4×IOD; 3×GOL; 1×3RS; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (BACE-DB-MUT) complex with N-(N-(4- acetamido-… | monomer | 1×0VB; 3×IOD; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with (2R)-N-((2S,3R)-1-(benzo[d][1,3]dioxol-5-yl)-3… | monomer | 8×IOD; 2×GOL; 1×0KN; | ||||
| Assess | ||||||
| Crystal structure of beta secetase in complex with 2-amino-3-methyl-6-((1S,2R)-2-(3'-methylbiphenyl… | monomer | 1×GOL; 1×B02; | ||||
| Assess | ||||||
| Crystal Structure of beta secetase in complex with (6S)-2-amino-3,6-dimethyl-6-[(1R,2R)-2-phenylcyc… | monomer | 3×IOD; 2×GOL; 1×DMS; 1×0B4; | ||||
| Assess | ||||||
| Crystal structure of BACE complex withBMC006 | monomer | 1×E5Y; | ||||
| Assess | ||||||
| Bace-1 in complex with a norstatine type inhibitor | monomer | 1×038; | ||||
| Assess | ||||||
| 1,4-Oxazine BACE1 inhibitors | monomer | 1×52K; 3×IOD; 1×CL; | ||||
| Assess | ||||||
| crystal structure of beta-site app-cleaving enzyme 1 (bace-wt) complex with N-(N-(4-amino-3,5- dich… | monomer | 1×0VA; 2×IOD; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with 2-aminoquinoline | monomer | 3×IOD; 1×DMS; 1×2AQ; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 2-((2-Amino-6-o-tolylquinolin-3-yl)methyl)-N-(… | monomer | 7×IOD; 2×GOL; 1×RVI; | ||||
| Assess | ||||||
| Crystal structure of BACE1 at pH 4.0 | monomer | |||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 6-(2-(3,3-Dimethylbut-1-ynyl)phenyl)quinolin-2… | monomer | 4×IOD; 1×RTH; | ||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Amino-6-o-tolylquinolin-3-yl)-N-cyclohexy… | monomer | 5×IOD; 3×GOL; 1×RTN; | ||||
| Assess | ||||||
| X-ray crystal structure of beta secretase complexed with N~3~-benzylpyridine-2,3-diamine | monomer | 2×IOD; 1×DMS; 1×8AP; | ||||
| Assess | ||||||
| Structure of BACE1 complex with a HEA-type inhibitor | monomer | |||||
| Assess | ||||||
| Structure of Bace-1 (Beta-Secretase) in Complex with 3-(2-Aminoquinolin-3-yl)-N-cyclohexyl-N-methyl… | monomer | 3×IOD; 2×GOL; 1×RTM; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3S)-3-(acetyla… | monomer | 1×PB7; 1×IOD; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl(methyl)amino)-1-… | monomer | 1×ZY1; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 3-(ethylamino)-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoro… | monomer | 1×VG6; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 4-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)… | monomer | 1×ZY0; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2… | monomer | 2×C44; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×VG4; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 1-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-… | monomer | 1×ZYE; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×XFI; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 3-(1,1-dioxidotetrahydro-2H-1,2-thiazin- 2-yl)-5-(ethylamino)-N-((1S,2… | monomer | 2×CM8; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×AA9; | ||||
| Assess | ||||||
| Bace1 in complex with the aminohydantoin Compound 102 | monomer | 1×ZOO; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 8-ethyl-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)amino)-1-… | monomer | 1×ZY2; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×VG5; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 6-ethyl-1-methyl-N-((1S)-2-oxo-1-(phenylmethyl)-3-(tetrahydro-2H-pyran… | monomer | 1×ZY4; | ||||
| Assess | ||||||
| Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | monomer | 1×996; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×VG5; | ||||
| Assess | ||||||
| Design and synthesis of potent hydroxyethylamine (hea) bace-1 inhibitors | monomer | 1×916; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-3-(((1S)-2-(cyclohexylamino)- 1-methyl-2-oxoethyl)amino)-2-… | monomer | 1×VG3; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 7-ethyl-N-((1S,2R)-2-hydroxy-1-(phenylmethyl)-3-(((3-(trifluoromethyl)… | monomer | 1×CM7; | ||||
| Assess | ||||||
| Human BACE-1 in complex with N-((1S,2R)-1-benzyl-2-hydroxy-3-((1,1,5- trimethylhexyl)amino)propyl)-… | monomer | 1×VG0; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors. X-RAY CRYSTAL STRUCTURE OF BETA SECRETASE COMPLEXED WITH COMP… | monomer | 1×ACT; 1×S8Z; | ||||
| Assess | ||||||
| Human BACE-1 in complex with 6-(ethylamino)-N-((1S,2R)-2-hydroxy-3-(((3-(methyloxy)phenyl)methyl)am… | monomer | 1×ZY3; 4×GOL; | ||||
| Assess | ||||||
| Bace1 in complex with the aminopyridine Compound 44 | monomer | 1×879; | ||||
| Assess | ||||||
| X-ray structure of Bace-1 in complex with compound 6g | monomer | 1×411; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with BMS-693391 AKA (2S)-2-(… | monomer | 1×PB0; | ||||
| Assess | ||||||
| BACE1 with Compound 1 | monomer | 1×251; | ||||
| Assess | ||||||
| Crystal structure of beta-site app-cleaving enzyme 1 (BACE-WT) complex with (2S)-2-((3R)-3-acetamid… | monomer | 1×PB8; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain | monomer | 1×WM9; | ||||
| Assess | ||||||
| BACE1 with Compound 2 | monomer | 1×462; | ||||
| Assess | ||||||
| Aminoimidazoles as BACE-1 Inhibitors: From De Novo Design to Ab- lowering in Brain | monomer | 1×KGG; | ||||
| Assess | ||||||
| Lead Generation of BACE1 Inhibitors by Coupling Non-amidine New Warheads to a Known Binding Scaffold | monomer | 1×GMF; 3×ACT; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6ej2.1.A | monomer | 0.86 | 1×B7E; | 99.60 | ||
| Assess | ||||||
5 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6ej2.1.A | monomer | 0.82 | 1×B7E; | 97.22 | |
| Assess | ||||||
| Isoform 3 | 6ej2.1.A | monomer | 0.81 | 99.56 | ||
| Assess | ||||||
| Isoform 4 | 6ej2.1.A | monomer | 0.81 | 96.50 | ||
| Assess | ||||||
| Isoform 5 | 6ej2.1.A | monomer | 0.86 | 96.00 | ||
| Assess | ||||||
| Isoform 6 | 6ej3.1.A | monomer | 0.83 | 93.33 | ||
| Assess | ||||||